Neuromuscular blocking agents: Difference between revisions

Line 10: Line 10:
|+Neuromuscular Blocking Agents
|+Neuromuscular Blocking Agents
!Agent
!Agent
|'''Time to onset''' <br> (seconds)
!'''Time to onset''' (seconds)
|'''Duration''' <br> (minutes)
!'''Duration''' (minutes)
!Side effects
!Side effects
!Clinical use
|-
|-
| '''Non-Depolarizing'''
| '''Non-Depolarizing'''
Line 47: Line 46:
|
|
*[[tachycardia]] (slight)
*[[tachycardia]] (slight)
(no hypotension)
*(no hypotension)
|-
|-
|}
|}

Revision as of 03:33, 24 February 2015

Background

  • Non-depolarizing
    • Competitively block binding of ACh to its receptors
  • Depolarizing
    • Depolarizing skeletal muscle fiber
    • Persistent depolarization makes the muscle fiber resistant to further stimulation by ACh

Types

Neuromuscular Blocking Agents
Agent Time to onset (seconds) Duration (minutes) Side effects
Non-Depolarizing
Succinylcholine fasciculations, post-operative pain
Depolarizing
Atracurium (Tracrium) 90 30 min or less[1]
  • hypotension, transiently,[1] by release of histamine
  • Toxic metabolite called laudanosine, greater accumulation in individuals with renal failure
Vecuronium (Norcuron) 60 30–40 Few, may cause prolonged paralysis and promote muscarinic block
Rocuronium (Zemuron) 75 45–70 may promote muscarinic block
Pancuronium (Pavulon) 90 180 or more

Sources

  1. 1.0 1.1 Cite error: Invalid <ref> tag; no text was provided for refs named Rang151